PDL BioPharma settles longstanding legal dispute with Genentech/Roche
This article was originally published in Scrip
Executive Summary
PDL BioPharma reached an agreement with Genentech and its parent company Roche to settle a longstanding legal dispute involving the smaller biotech's antibody humanization technology, although investors of the Incline, Nevada-based firm appeared discontent with the deal, driving shares down 3% on 3 February.